LexaGene Holdings Inc. (CVE:LXG – Get Free Report) was down 19.2% during mid-day trading on Thursday . The company traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,375 shares changed hands during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Price Performance
The company has a market capitalization of C$14.77 million, a P/E ratio of -1.31 and a beta of 2.26. The company’s 50-day simple moving average is C$0.11 and its 200 day simple moving average is C$0.11. The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 138.01.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
See Also
- Five stocks we like better than LexaGene
- 3 Fintech Stocks With Good 2021 Prospects
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Pros And Cons Of Monthly Dividend Stocks
- MarketBeat Week in Review – 11/18 – 11/22
- The How And Why of Investing in Oil Stocks
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
